Karpus Investment Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Karpus Investment Management’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-238,085	Closed	-$2.48M	–	401
2022 Q4	$2.48M	Sell	238,085 -8,780	-4%	-$90.2K	0.08%	195
2022 Q3	$2.52M	Sell	246,865 -10,900	-4%	-$111K	0.09%	222
2022 Q2	$2.61M	Hold	257,765	–	–	0.09%	228
2022 Q1	$2.6M	Buy	257,765 +10,300	+4%	+$103K	0.08%	205
2021 Q4	$2.47M	Buy	+247,465	New	+$2.47M	0.07%	208

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Karpus Investment Management's OCEA Position: Q1 2023 in Review

Karpus Investment Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 238,085 shares — an estimated $2.48M sold.

Karpus Investment Management first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $2.61M in Q2 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

Karpus Investment Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Karpus Investment Management sold 238,085 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $2.48M.
Karpus Investment Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Karpus Investment Management's Ocean Biomedical, Inc. Common Stock position peaked at $2.61M in Q2 2022.
17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Karpus Investment Management's 13F filing for Q1 2023, filed 11 May 2023.